(R)-3,3'-Bis[(10-phenylanthracen-9-yl)]-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate, 97%, 250mg

1-Bromo-3,5-dinitrobenzene, 95.0%, 1g

N-(3-METHOXYPYRAZIN-2-YL)-4-NITROBENZENESULFONAMIDE, 95.0%, 250mg

Pipettes jaugées 1 marque classe B, 50 ml, 6 pièces

5-(4-Difluoromethoxy-phenyl)-1 H -pyrazole-3-carboxylic acid, 95+%, 1g

1-tert-Butyl 4-methyl 4-aminopiperidine-1,4-dicarboxylate, 95.0%, 250mg

4-Hydroxy-1,5-naphthyridine, 95.0%, 250mg

methyl 2-(4-chloro-6-methoxypyrimidin-5-yl)acetate, 95.0%, 250mg

(2-Amino-5-bromophenyl)dimethylphosphine oxide, 98%, 5g

9,10-Di(1-naphthyl)anthracene>98.0%(HPLC)1g

(4aR,7aS)-Hexahydro-2H-[1,4]dioxino[2,3-c]pyrrole hydrochloride, 95.0%, 1g

5-(3-BROMO-4-(DIMETHYLAMINO)PHENYL)-2,2-DIMETHYL-2,3,5,6-TETRAHYDROBENZO[A]PHENANTHRIDIN-4(1H)-ONE, 95%, 1mg

N-Methylbenzenecarbothioamide, 250mg